美国 · SEC FORM 4
Jazz Pharmaceuticals plc
JAZZ · Nasdaq · CIK 0001232524 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
71 同一窗口内观察到的 Form 4 交易行
21 sales · 50 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 11 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-05-12 · Mulligan Seamus.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 5,479,715
- 上期报告
- 4,676,811
- 日均成交量
- 845,809
- 回补天数
- 6.5
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-05-12 | Mulligan Seamus | 买入 (P) | Ordinary Shares | 1,621 | USD 103.00 | USD 166,963 | SEC 申报 ↗ |
| 2025-05-09 | Mulligan Seamus | 买入 (P) | Ordinary Shares | 100,000 | USD 98.26 | USD 9,825,726 | SEC 申报 ↗ |
| 2024-03-01 | Johnson Philip L | 买入 (P) | Ordinary Shares | 12,000 | USD 119.65 | USD 1,435,800 | SEC 申报 ↗ |
| 2020-05-27 | Mulligan Seamus | 买入 (P) | Ordinary Shares | 35,000 | USD 111.26 | USD 3,894,061 | SEC 申报 ↗ |
| 2020-05-26 | Mulligan Seamus | 买入 (P) | Ordinary Shares | 15,000 | USD 110.65 | USD 1,659,750 | SEC 申报 ↗ |
Form 4 申报证据
151 transaction lines in the latest 365-day window; 689 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | GALA RENEE D | 卖出 (S) | Ordinary Shares | 2,000 | USD 236.40 | USD 472,800 | SEC 申报 ↗ |
| 2026-10-01 | COZADD BRUCE C | 卖出 (S) | Ordinary Shares | 6,000 | USD 230.33 | USD 1,381,980 | SEC 申报 ↗ |
| 2026-09-10 | Patil Neena M | 卖出 (S) | Ordinary Shares | 1,200 | USD 240.94 | USD 289,128 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | GALA RENEE D | 卖出 (S) | Ordinary Shares | 2,000 | USD 236.40 | USD 472,800 | SEC 申报 ↗ |
| 2026-10-01 | COZADD BRUCE C | 卖出 (S) | Ordinary Shares | 6,000 | USD 230.33 | USD 1,381,980 | SEC 申报 ↗ |
| 2026-09-10 | Patil Neena M | 卖出 (S) | Ordinary Shares | 1,200 | USD 240.94 | USD 289,128 | SEC 申报 ↗ |
| 2026-09-08 | Henderson Mary Elizabeth | 代扣税 (F) | Ordinary Shares | 1,427 | USD 243.01 | USD 346,776 | SEC 申报 ↗ |
| 2026-09-08 | GALA RENEE D | 卖出 (S) | Ordinary Shares | 2,000 | USD 243.03 | USD 486,060 | SEC 申报 ↗ |
| 2026-09-08 | GALA RENEE D | 代扣税 (F) | Ordinary Shares | 1,967 | USD 246.81 | USD 485,475 | SEC 申报 ↗ |
| 2026-09-01 | COZADD BRUCE C | 卖出 (S) | Ordinary Shares | 6,000 | USD 250.13 | USD 1,500,780 | SEC 申报 ↗ |
| 2026-08-31 | Winningham Rick E | 代扣税 (F) | Ordinary Shares | 1,706 | USD 241.42 | USD 411,857 | SEC 申报 ↗ |
| 2026-08-31 | Smith Mark Douglas | 代扣税 (F) | Ordinary Shares | 1,706 | USD 241.42 | USD 411,857 | SEC 申报 ↗ |
| 2026-08-31 | RIEDEL NORBERT G | 代扣税 (F) | Ordinary Shares | 1,706 | USD 241.42 | USD 411,857 | SEC 申报 ↗ |
| 2026-08-31 | McSharry Heather Ann | 代扣税 (F) | Ordinary Shares | 1,855 | USD 241.42 | USD 447,827 | SEC 申报 ↗ |
| 2026-08-31 | LOVE TED W | 代扣税 (F) | Ordinary Shares | 743 | USD 241.41 | USD 179,369 | SEC 申报 ↗ |
| 2026-08-31 | Kennedy Patrick | 代扣税 (F) | Ordinary Shares | 1,855 | USD 241.41 | USD 447,818 | SEC 申报 ↗ |
| 2026-08-31 | Henderson Mary Elizabeth | 代扣税 (F) | Ordinary Shares | 2,092 | USD 241.41 | USD 505,040 | SEC 申报 ↗ |
| 2026-08-31 | Hamill Laura | 代扣税 (F) | Ordinary Shares | 1,706 | USD 241.41 | USD 411,849 | SEC 申报 ↗ |
| 2026-08-31 | ENRIGHT PATRICK G | 代扣税 (F) | Ordinary Shares | 1,706 | USD 241.42 | USD 411,857 | SEC 申报 ↗ |
| 2026-08-31 | Cook Jennifer E. | 代扣税 (F) | Ordinary Shares | 1,706 | USD 241.41 | USD 411,849 | SEC 申报 ↗ |
| 2026-08-31 | COZADD BRUCE C | 代扣税 (F) | Ordinary Shares | 1,219 | USD 241.41 | USD 294,281 | SEC 申报 ↗ |
| 2026-08-27 | Iannone Robert | 卖出 (S) | Ordinary Shares | 76,921 | USD 249.70 | USD 19,207,166 | SEC 申报 ↗ |
| 2026-08-27 | Iannone Robert | 期权行权/转换 (M) | Ordinary Shares | 57,500 | USD 125.84 | USD 7,235,860 | SEC 申报 ↗ |
| 2026-08-05 | Winningham Rick E | 奖励/授予 (A) | Ordinary Shares | 1,605 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-05 | Smith Mark Douglas | 奖励/授予 (A) | Ordinary Shares | 1,605 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-05 | RIEDEL NORBERT G | 奖励/授予 (A) | Ordinary Shares | 1,605 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-05 | Pearce Samantha | 代扣税 (F) | Ordinary Shares | 780 | USD 261.62 | USD 204,064 | SEC 申报 ↗ |
| 2026-08-05 | Mulligan Seamus | 奖励/授予 (A) | Ordinary Shares | 1,605 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-05 | McSharry Heather Ann | 奖励/授予 (A) | Ordinary Shares | 1,605 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-05 | LOVE TED W | 奖励/授予 (A) | Ordinary Shares | 1,605 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-05 | Kennedy Patrick | 奖励/授予 (A) | Ordinary Shares | 1,605 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-05 | Hamill Laura | 奖励/授予 (A) | Ordinary Shares | 1,605 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-05 | ENRIGHT PATRICK G | 奖励/授予 (A) | Ordinary Shares | 1,605 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | JAZZ |
| CIK | 0001232524 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 689 transaction lines from 2020-01-02 to 2026-10-06 10 P purchase lines · 306 S sale lines · 373 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.